Combining D-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke

Journal of Neurophysiology

Volumn 111, Issue 12, 2014, Pages 2516-2524

  Cherry, Kendra M ^a   Lenze, Eric J ^b   Lang, Catherine E ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavioral training; D cycloserine; Motor learning; Stroke

Indexed keywords

CYCLOSERINE; PLACEBO; AMINO ACID RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; ARTIFICIAL FEEDING; BODY EQUILIBRIUM; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COGNITION; COGNITIVE REHABILITATION; CONTROLLED STUDY; DISEASE SIMULATION; DOUBLE BLIND PROCEDURE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; LEARNING; LOCOMOTION; MALE; MONOTHERAPY; MOTOR LEARNING; MOTOR PERFORMANCE; PRETEST POSTTEST CONTROL GROUP DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TASK PERFORMANCE; DRUG EFFECTS; FEEDING BEHAVIOR; KINESIOTHERAPY; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; STROKE;

ADULT; COGNITION; CYCLOSERINE; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; EXERCISE THERAPY; FEEDING BEHAVIOR; FEMALE; HUMANS; LEARNING; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; POSTURAL BALANCE; STROKE;

EID: 84902682906     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00882.2013     Document Type: Article

References (55)

1. Balota DA, Yap MJ, Cortese MJ, Hutchison KA, Kessler B, Loftis B, Neely JH, Nelson DL, Simpson GB, Treiman R. The English Lexicon Project. Behav Res Methods 39: 445-459, 2007.
2. Barbay S, Zoubina EV, Dancause N, Frost SB, Eisner-Janowicz I, Stowe AM, Plautz EJ, Nudo RJ. A single injection of D-amphetamine facilitates improvements in motor training following a focal cortical infarct in squirrel monkeys. Neurorehabil Neural Repair 20: 455-458, 2006.
3. Berg K, Wood-Dauphinee S, Williams JI. The balance scale: reliability assessment with elderly residents and patients with an acute stroke. Scand J Rehabil Med 27: 27-36, 1995.
4. Blennerhassett JM, Carey LM, Matyas TA. Clinical measures of handgrip limitation relate to impaired pinch grip force control after stroke. J Hand Ther 21: 245-252; quiz 253, 2008.
5. Blum L, Korner-Bitensky N. Usefulness of the Berg Balance Scale in stroke rehabilitation: a systematic review. Phys Ther 88: 559-566, 2008.
6. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20: 864-870, 1989.
7. Bunge SA, Burrows B, Wagner AD. Prefrontal and hippocampal contributions to visual associative recognition: interactions between cognitive control and episodic retrieval. Brain Cogn 56: 141-152, 2004.
8. Butefisch CM, Davis BC, Wise SP, Sawaki L, Kopylev L, Classen J, Cohen LG. Mechanisms of use-dependent plasticity in the human motor cortex. Proc Natl Acad Sci USA 97: 3661-3665, 2000.
9. Castronova J. Discovery learning for the 21st century: what is it and how does it compare to traditional learning in effectiveness in the 21st century? Action Res Exchange 1: 1-12, 2002.
10. Curtze C, Postema K, Akkermans HW, Otten B, Hof AL. The Narrow Ridge Balance Test: a measure for one-leg lateral balance control. Gait Posture 32: 627-631, 2010.
11. Davis M, Ressler K, Rothbaum BO, Richardson R. Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry 60: 369-375, 2006.
12. Davis M. Facilitation of fear extinction and psychotherapy by D-cycloserine. Zeitschrift Fur Psychologie 218: 149-150, 2010.
13. Dhawan J, Benveniste H, Nawrocky M, Smith SD, Biegon A. Transient focal ischemia results in persistent and widespread neuroinflammation and loss of glutamate NMDA receptors. Neuroimage 51: 599-605, 2010.
14. Dhawan J, Benveniste H, Luo Z, Nawrocky M, Smith SD, Biegon A. A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke. Future Neurol 6: 823-834, 2011.
15. Duncan PW, Wallace D, Studenski S, Lai SM, Johnson D. Conceptualization of a new stroke-specific outcome measure: the stroke impact scale. Top Stroke Rehabil 8: 19-33, 2001.
16. Duncan PW, Sullivan KJ, Behrman AL, Azen SP, Wu SS, Nadeau SE, Dobkin BH, Rose DK, Tilson JK; LEAPS Investigative Team. Protocol for the Locomotor Experience Applied Post-stroke (LEAPS) trial: a randomized controlled trial. BMC Neurol 7: 39, 2007.
17. Duzel E, Habib R, Rotte M, Guderian S, Tulving E, Heinze HJ. Human hippocampal and parahippocampal activity during visual associative recognition memory for spatial and nonspatial stimulus configurations. J Neurosci 23: 9439-9444, 2003.
18. Fakouhi TD, Jhee SS, Sramek JJ, Benes C, Schwartz P, Hantsburger G, Herting R, Swabb EA, Cutler NR. Evaluation of cycloserine in the treatment of Alzheimer's disease. J Geriatr Psychiatry Neurol 8: 226-230, 1995.
19. Flood JF, Morley JE, Lanthorn TH. Effect on memory processing by D-cycloserine, an agonist of the NMDA/glycine receptor. Eur J Pharmacol 221: 249-254, 1992.
20. Friedman LK, Belayev L, Alfonso OF, Ginsberg MD. Distribution of glutamate and preproenkephalin messenger RNAs following transient focal cerebral ischemia. Neuroscience 95: 841-857, 2000.
21. Gottlieb JD, Cather C, Shanahan M, Creedon T, Macklin EA, Goff DC. D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia. Schizophr Res 131: 69-74, 2011.
22. Guastella AJ, Richardson R, Lovibond PF, Rapee RM, Gaston JE, Mitchell P, Dadds MR. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry 63: 544-549, 2008.
23. Heresco-Levy U, Gelfin G, Bloch B, Levin R, Edelman S, Javitt DC, Kremer I. A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression. Int J Neuropsychopharmacol 16: 501-506, 2013.
24. Hess G, Aizenman CD, Donoghue JP. Conditions for the induction of long-term potentiation in layer II/III horizontal connections of the rat motor cortex. J Neurophysiol 75: 1765-1778, 1996.
25. Hoffman M, Schrader J, Applegate T, Koceja D. Unilateral postural control of the functionally dominant and nondominant extremities of healthy subjects. J Athl Train 33: 319-22, 1998.
26. Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry 63: 298-304, 2006a.
27. Hofmann SG, Pollack MH, Otto MW. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Rev 12: 208-217, 2006b.
28. Hood WF, Compton RP, Monahan JB. D-Cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett 98: 91-95, 1989.
29. Javitt DC. Harnessing N-methyl-D-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies. Am J Psychiatry 170: 699-702, 2013.
30. Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294: 1030-1038, 2001.
31. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 140: 734-739, 1983.
32. Kuo MF, Unger M, Liebetanz D, Lang N, Tergau F, Paulus W, Nitsche MA. Limited impact of homeostatic plasticity on motor learning in humans. Neuropsychologia 46: 2122-2128, 2008.
33. Kuriyama K, Honma M, Soshi T, Fujii T, Kim Y. Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial. Psychopharmacology (Berl) 218: 589-697, 2011.
34. Lang CE, Wagner JM, Dromerick AW, Edwards DF. Measurement of upper-extremity function early after stroke: properties of the action research arm test. Arch Phys Med Rehabil 87: 1605-1610, 2006.
35. Lo AC, Guarino PD, Richards LG, Haselkorn JK, Wittenberg GF, Federman DG, Ringer RJ, Wagner TH, Krebs HI, Volpe BT, Bever CT Jr, Bravata DM, Duncan PW, Corn BH, Maffucci AD, Nadeau SE, Conroy SS, Powell JM, Huang GD, Peduzzi P. Robot-assisted therapy for long-term upper-limb impairment after stroke. N Engl J Med 362: 1772-1783, 2010.
36. McNevin NH, Shea CH, Wulf G. Increasing the distance of an external focus of attention enhances learning. Psychol Res 67: 22-29, 2003.
37. Nitsche MA, Jaussi W, Liebetanz D, Lang N, Tergau F, Paulus W. Consolidation of human motor cortical neuroplasticity by D-cycloserine. Neuropsychopharmacology 29: 1573-1578, 2004.
38. Norberg MM, Krystal JH, Tolin DF. A meta-analysis of D-Cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry 63: 1118-1126, 2008.
39. Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, Hofmann SG, Eisenmenger K, Krystal JH, Pollack MH. Efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry 67: 365-370, 2010.
40. Parnas AS, Weber M, Richardson R. Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats. Neurobiol Learn Mem 83: 224-231, 2005.
41. Quartermain D, Mower J, Rafferty MF, Herting RL, Lanthorn TH. Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention. Eur J Pharmacol 257: 7-12, 1994.
42. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61: 1136-1144, 2004.
43. Rodebaugh TL, Lenze EJ. Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy. J Clin Psychiatry 74: 415-416, 2013.
44. Schaefer SY, Lang CE. Using dual tasks to test immediate transfer of training between naturalistic movements: a proof-of-principle study. J Mot Behav 44: 313-327, 2012.
45. Simeon J, Fink M, Itil TM, Ponce D. D-Cycloserine therapy of psychosis by symptom provocation. Compr Psychiatry 11: 80-88, 1970.
46. Taubert M, Draganski B, Anwander A, Müller K, Horstmann A, Villringer A, Ragert P. Dynamic properties of human brain structure: learning-related changes in cortical areas and associated fiber connections. J Neurosci 30, 11670-11677, 2010.
47. Teo JT, Swayne OB, Rothwell JC. Further evidence for NMDA-dependence of the after-effects of human theta burst stimulation. Clin Neurophysiol 118: 1649-1651, 2007.
48. Toraman A, Yildirim NU. The falling risk and physical fitness in older people. Arch Gerontol Geriatr 51: 222-226, 2010.
49. Vellas BJ, Wayne SJ, Romero L, Baumgartner RN, Rubenstein LZ, Garry PJ. One-leg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc 45: 735-738, 1997.
50. Warburton EC, Barker GR, Brown MW. Investigations into the involvement of NMDA mechanisms in recognition memory. Neuropharmacology 74: 41-47, 2013.
51. Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE, Cannistraro P, Jenike MA, Rauch SL. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry 165: 335-41; quiz 409, 2008.
52. Wolf SL, Winstein CJ, Miller JP, Taub E, Uswatte G, Morris D, Giuliani C, Light KE, Nichols-Larsen D; EXCITE Investigators. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA 296, 2095-2104, 2006.
53. Wulf G, Weigelt M, Poulter D, McNevin N. Attentional focus on suprapostural tasks affects balance learning. Q J Exp Psychol A 56: 1191-211, 2003.
54. Yaka R, Biegon A, Grigoriadis N, Simeonidou C, Grigoriadis S, Alexandrovich AG, Matzner H, Schumann J, Trembovler V, Tsenter J, Shohami E. D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury. FASEB J 21: 2033-2041, 2007.
55. Yonelinas AP, Hopfinger JB, Buonocore MH, Kroll NE, Baynes K. Hippocampal, parahippocampal and occipital-temporal contributions to associative and item recognition memory: an fMRI study. Neuroreport 12: 359-363, 2001.